It is not yet known whether the detection or elevation of BCL2A1-gene-related markers (i.e., cell-free fetal [cff] DNA and cff-RNA) in maternal plasma can be used to predict either the presence or the stage progression of acute HCA in the EPM. Here, BCL2A1 is linked to hepatocellular adenoma.